Abstract
Abstract: Transcatheter aortic valve replacement (TAVR) is indicated in some patients with severe aortic stenosis for whom surgical intervention is not deemed appropriate. This article explores when TAVR may be the preferred treatment option over surgical aortic valve replacement and discusses various prosthetic valve devices. There are several FDA-approved prosthetic valve devices used in clinical practice including: balloon-expandable devices (SAPIEN 3, SAPIEN, and SAPIEN XT), self-expanding devices (Evolut R, Evolut PRO, ACURATE Neo, Portico, and Allegra), and mechanically expandable devices such as the LOTUS, which is currently unavailable as the delivery system is being refined.1 Additionally, TAVR diagnostic screenings, procedure, complications, postoperative management, and nursing considerations are also outlined.